2024 annual financial data
Lisata Therapeutics 2024 Operating margin
Lisata Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -2,240.9%.
Operating income was -22,409,000 USD and net income was -19,985,000 USD.
Operating cash flow was -19,356,000 USD.
Get free Lisata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,000,000 USD
- Operating income
- -22,409,000 USD
- Net income
- -19,985,000 USD
- Operating cash flow
- -19,356,000 USD